Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chandra Belani, M.D.
Milton S. Hershey Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Cancer Center
Tucson, Arizona, United States
- Pacific Coast Hematology Oncology Group
Fountain Valley, California, United States
- Pasco Hernando Oncology
New Port Richey, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- the University of Chicago
Chicago, Illinois, United States
- University of Maryland, Greenebaun Cancer Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Nebraska Medical Center
Omaha, Nebraska, United States
- Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Va Sierra Nevada Health Care System
Reno, Nevada, United States
- New Mexico Oncology Hematology Consultants
Albuquerque, New Mexico, United States
- Columbia Presbyterian Medical Center
New York, New York, United States
- Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- University of Pittsburg Cancer Institute
Pittsburgh, Pennsylvania, United States
- the Family Cancer Center
Collierville, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Southwest Regional Cancer Center
Austin, Texas, United States
- Center for Oncology Research and Treatment
Dallas, Texas, United States
- East Texas Medical Center
Tyler, Texas, United States
- Danville Hematology Oncology
Danville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2006
- Primary completion
- 3 Mar 2009
- Completion
- 7 Apr 2009
- Last update posted
- 22 Dec 2021
- Registered enrollment
- 187
- Registry id
- NCT00372073
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.